/newsroom/taxonomy/term/1008/all en /newsroom/channels/news/prospects-new-treatments-diabetes-through-metabolic-products-intestinal-flora-320574 <p>In a study published in the journal <a href="https://www.cell.com/cell-reports/pdf/S2211-1247(20)30091-7.pdf"><i>Cell Reports</i></a>, researchers at UUֱ��, Kyoto University and INSERM/University of Paris show that an organic compound produced by the intestinal flora, the metabolite 4-Cresol, exhibits protective effects against type 1 and type 2 diabetes by stimulating the proliferation and function of insulin-producing beta cells in the pancreas. These results pave the way for new therapeutic options that could improve the situation of millions of patients.</p> Wed, 19 Feb 2020 19:03:25 +0000 justin.dupuis@mcgill.ca 199034 at /newsroom /newsroom/channels/news/many-faces-diabetes-addressing-heterogeneity-complex-disease-285649 <p><em>Comment by Rob Sladek, UUֱ�� Associate Professor in the Departments of Medicine and Human Genetics</em></p> Tue, 06 Mar 2018 18:54:08 +0000 justin.dupuis@mcgill.ca 33668 at /newsroom /newsroom/channels/news/mcgill-research-team-studies-how-calcium-compounds-accumulate-arteries-284352 <p><span>Team leader Marta Cerruti, using the tools of the Canadian Light Source, has examined the mineralized arteries of genetically modified laboratory mice and found that the pathway in the body that leads to what laypeople call “hardening of the arteries” is not what medical experts previously assumed.</span></p> Wed, 31 Jan 2018 16:07:08 +0000 cynthia.lee@mcgill.ca 32911 at /newsroom /newsroom/channels/news/pregnancy-related-conditions-taken-together-leave-moms-and-dads-risk-282694 <p>Research has already shown that women who develop either diabetes or high blood pressure during pregnancy are at risk of getting type 2 diabetes, high blood pressure or heart disease years later. Now, a new study from a team at the Research Institute of the UUֱ�� Health Centre (RI-MUHC) and UUֱ�� shows that the risk of developing those conditions post pregnancy is drastically higher if the women had both diabetes and high blood pressure during pregnancy. The study, published today in the <em>American Journal of Epidemiology</em>, doesn’t end with the mother’s risks.</p> Tue, 14 Nov 2017 18:51:30 +0000 priya.pajel@mail.mcgill.ca 32666 at /newsroom /newsroom/channels/news/adverse-effects-and-incretin-based-drugs-diabetes-261900 <p><a href="/newsroom"><strong><em>UUֱ�� Newsroom</em></strong></a></p> <p><em>Extensive population-based studies on a popular group of drugs used to treat type 2 diabetes revealed no association with acute pancreatitis, but increased risk of bile duct and gallbladder disease</em></p> Mon, 01 Aug 2016 14:19:07 +0000 nima.adibpour@mail.mcgill.ca 26046 at /newsroom /newsroom/channels/news/new-path-discovery-parkinsons-disease-261519 <p><em><b>UUֱ�� Newsroom</b></em></p> <p><em>Neuron cell death may be caused by overactive immune system </em></p> <p>A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at UUֱ�� have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.</p> Tue, 28 Jun 2016 14:27:43 +0000 nima.adibpour@mail.mcgill.ca 25999 at /newsroom /newsroom/channels/news/how-depression-may-compound-risk-type-2-diabetes-260358 <p><strong><em>By Fergus Grieve, <a href="/newsroom">UUֱ�� Newsroom</a></em></strong></p> <p><em>Depression, metabolic factors combine to boost risk of developing diabetes, study finds </em></p> <p>Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from UUֱ��, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.</p> Tue, 12 Apr 2016 14:27:45 +0000 nima.adibpour@mail.mcgill.ca 25701 at /newsroom /newsroom/channels/news/world-health-day-and-diabetes-april-7-2016-260192 <p>About 422 million people worldwide have diabetes, a number likely to more than double in the next 20 years, according to research published today by the World Health Organization. <span><a href="http://www.who.int/campaigns/world-health-day/2016/en/">April 7, 2016 is World Health Day </a>and the focus this year is on diabetes.</span></p> Wed, 06 Apr 2016 19:46:03 +0000 vincent.allaire@mcgill.ca 25678 at /newsroom /newsroom/channels/news/no-increased-heart-failure-incretin-based-drugs-259863 <p><strong><em>UUֱ�� Newsroom</em></strong></p> <p><em>Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications</em></p> <p>Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the <em>New England Journal of Medicine</em>.</p> Wed, 23 Mar 2016 14:49:58 +0000 nima.adibpour@mail.mcgill.ca 25548 at /newsroom /newsroom/channels/news/diabetes-drug-found-not-cause-pancreatic-cancer-259218 <p><em><span><b>By Tod Hoffman, <a href="http://www.ladydavis.ca/en/home">Lady Davis Institute for Medical Research</a></b></span></em></p> <p><span>The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ).</span></p> <p>The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.</p> Mon, 22 Feb 2016 19:09:23 +0000 laurie.devine@mcgill.ca 25341 at /newsroom /newsroom/barry-posner Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 23620 at /newsroom /newsroom/jean-francois-yale Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 22926 at /newsroom /newsroom/jun-li-liu Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 22830 at /newsroom /newsroom/constantin-polychronakos Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 23994 at /newsroom /newsroom/siegfried-hekimi Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 23856 at /newsroom